Skip to main content
MTD logo

Mettler-Toledo International Inc.

MTDNYSEHealthcareDiagnostics & Research

$1,670.29Today:- (-)1Y +17.17%

As of Oct 23, 2026 close

Market cap
$33.68B
P/E (TTM)
37.19
Forward P/E
34.74
Dividend yield
-
52-week range
$1,023.05$1,659.70
Volume (live)
-
Avg. volume (3M)
220.30K

Mettler-Toledo International (MTD) Stock Price & Financial Analysis

Mettler-Toledo International Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$1,652.98 - $1,686.98
52-Week High$1,659.70
52-Week Low$1,023.05
Open$1,678.04
Volume (last close)199.33K
Average Volume (3M)220.30K
Earnings & Profitability
Revenue (TTM)4.13B
Net Income (TTM)905.61M
Free Cash Flow (TTM)863.97M
EPS (TTM)$44.44
Profit Margin21.91%
Operating Margin28.34%
Return on Equity (ROE)7062.40%
Debt to Equity164.70
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Size & Valuation
Market Cap33.68B
Shares Outstanding20.17M
P/E Ratio (TTM)37.19
Forward P/E34.74
Price to Sales (P/S)8.15
Price to Book (P/B)2626.81
EV/EBITDA27.73
Technical Indicators
50-Day MA$1,451.68
200-Day MA$1,329.17
1-Year Change+17.17%

Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology

Compare MTD with other stocks

Mettler-Toledo International at a Glance

As of the Oct 23, 2026 close, Mettler-Toledo International (MTD) has a market capitalization of $33.68B. The stock trades at 37.2× trailing earnings, 34.7× forward earnings and 8.2× sales. Over the trailing twelve months it earned $905.61M on revenue of $4.13B (a 21.9% profit margin) and generated $863.97M of free cash flow. Revenue grew 6.9% year over year.

As of its latest reported balance sheet, it holds $51.38M in cash and securities against $2.11B of debt, a net debt position of $2.06B.

Mettler-Toledo International does not currently pay a dividend.

The share price is up 17.2% over the past year. At $1670.29 (the Oct 23, 2026 close) it sits near the top of its 52-week range of $1023.05 to $1659.70, above its 200-day moving average of $1329.17.

Based on 12 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $1530.00, 8.4% below the Oct 23, 2026 close.

Frequently Asked Questions About Mettler-Toledo International

What is the current stock price for MTD?

As of the Oct 23, 2026 close, MTD stock trades at $1670.29. The 52-week range is $1,023.05–$1,659.70, with a day range of $1652.98–$1686.98.

What is the P/E ratio for MTD?

As of the Oct 23, 2026 close, Mettler-Toledo International's trailing twelve-month (TTM) P/E ratio is 37.2, meaning investors pay $37.2 for every $1 of annual earnings. The forward P/E is 34.7, reflecting analyst expectations for future earnings. Mettler-Toledo International operates in the Healthcare sector.

Does MTD pay dividends?

Mettler-Toledo International does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.

What do analysts recommend for MTD?

Based on ratings from 12 professional analysts over the last 90 days, the consensus for MTD is Hold. The average 12-month price target is $1530.00, a 8.4% downside from the Oct 23, 2026 close of $1670.29.

What is the market cap of MTD?

As of the Oct 23, 2026 close, Mettler-Toledo International's market capitalization is $33.68B, classifying it as a large-cap company. Mettler-Toledo International operates in the Healthcare sector within the Diagnostics & Research industry.